Actively Recruiting
Evaluating the Arthrex LoopLoc Device for Hip Capsule Repair During Primary Hip Arthroscopy A Multi-Center Treatment Study
Led by American Hip Institute · Updated on 2025-01-01
80
Participants Needed
1
Research Sites
104 weeks
Total Duration
AI-Summary
What this Trial Is About
Researchers are evaluating the Arthrex LoopLocTM device to see if it provides better capsular closure during hip arthroscopy compared to other treatments. The hip capsule is the tissue surrounding the hip joint that supports and stabilizes it, and it must be cut during hip arthroscopy. Traditional repair methods use knotted sutures that may cause irritation and scar tissue, potentially leading to pain. This study aims to compare outcomes between patients who receive the LoopLocTM device and those who do not after primary hip arthroscopy. Participants will either have the LoopLocTM device used for capsular closure during their hip arthroscopy or will undergo the procedure without this device as part of a control group. This prospective, multi-center study involves following patients for two years after surgery. Researchers will collect patient-reported and clinical outcomes to evaluate the feasibility and benefits of the knotless LoopLocTM device. During the two-year follow-up, patients will regularly visit their providers and researchers to assess outcomes such as the Modified Harris Hip Score, Non-Arthritic Hip Score, International Hip Outcome Tool, Hip Outcome Score Sports-Specific Subscale, Visual Analog Scale, and patient satisfaction. The study will monitor and compare these measures to determine if using the LoopLocTM device leads to improved results after hip arthroscopy.
CONDITIONS
Brief Title
Knotless Implants As an Alternative for Capsular Closure in Primary Hip Arthroscopy: a Prospective, Multi-Center Study
Research Team
A
Alexandra Mantice
B
Benjamin Domb
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here